The flu season is getting started

After a virtually non-existent flu season in 2020/2021 and with the revival of public life and the relaxation of social distancing measures, there is increasing concern that a large flu wave could ...

New partnership: IDS and EUROIMMUN

We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July ...

Impact of SARS-CoV-2 variants on antibody tests

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against ...

Oncgnostics and EUROIMMUN Announce Collaboration to Distribute Cervical Cancer Test GynTect

EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the ...

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected COVID-19-Patients

New PCR test to differentiate between COVID-19 and flu

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus ...

Novel ELISA for Quantification of Antibodies against S1 Protein of SARS-CoV-2

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein.
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and ...

Back to top